With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at the Obesity Society Annual Meeting (ObesityWeek) 2024. For the presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback